Clarify Medical Stock
A developer of a handheld medical device used to treat psoriasis, eczema and vitiligo .
Sign up today and learn more about Clarify Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Clarify Medical Stock
Clarify Medical is mobile, handheld UVB therapy. Clarify is innovating a well established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients.
Funding History
| May 2014 | $0 |
|---|---|
| December 2015 | $1.4M |
| April 2016 | $400K |
| April 2016 | $0 |
| November 2016 | $3.6M |
| June 2017 | $0 |
| October 2017 | $0 |
| July 2018 | $1.0M |
| October 2019 | $18.0M |
Management
Co-Founder & CEO
Martyn Gross
Co-Founder
Remo Qajar
VP of Research and Development
Andre Gamelin
CEO
Jim Sweeney
Press
sandiegouniontribune - Feb, 19 2024
Zerigo Health appoints new chief executive officer - The San Diego Union-Tribunehitconsultant - Feb, 19 2024
Zerigo Health Appoints Eric Zerneke as Chief Growth Officerprnewswire - Dec, 19 2023
Zerigo Health Appoints Tim Raducha-Grace as Chief Platform Officerprnewswire - Aug, 7 2023
Zerigo Health Appoints Lisa Rometty as Chief Executive Officerbusinesswire - Sep, 16 2022
Zerigo Health Announces Release of Eczema SolutionEquityZen Recognized As:
